Rhythm Pharmaceuticals Inc reports results for the quarter ended in January 1 - Earnings Summary

Rhythm Pharmaceuticals

06/11/2024 04:42

* Rhythm Pharmaceuticals Inc  RYTM.OQ  reported a quarterly
adjusted loss of 73 cents​​ per share for the quarter ended
January 1, higher than the same quarter last year, when the
company reported EPS of -76 cents.  The mean expectation of
eleven analysts for the quarter was for a loss of 80 cents per
share. Wall Street expected results to range from $-1.23 to -57
cents per share.
    * Revenue rose 47.8% to $33.25 million from a year ago;
analysts
expected $32.52 million. 
    * Rhythm Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 73 cents​.
    * The company reported a quarterly loss of $44.97 million.
    * Rhythm Pharmaceuticals Inc shares had risen by 1.1% this
quarter and gained 15.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.7%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Rhythm
Pharmaceuticals Inc is $64.00 
This summary was machine generated from LSEG data November 6 at
04:42 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.80          -0.73          Beat
 Jun. 30 2024      -0.71          -0.69          Beat
 Mar. 31 2024      -2.16          -2.35          Missed
 Dec. 31 2023      -0.70          -0.70          Met